FDA Warns of Ocaliva Liver Injury Risks Linked to Autoimmune Disorder Drug
The FDA first issued a warning regarding the risk of serious liver injury with Ocaliva in September 2017. In early […]
The FDA first issued a warning regarding the risk of serious liver injury with Ocaliva in September 2017. In early […]
This webinar explores key trends shaping the pharmaceutical industry’s future featured in Clarivate’s 2025 Drugs to Watch™ report. Industry experts